CompoAtlas

EQUILIBRE NERVEUX

Food supplement declared in France, declaration No 2017-3-1458, decision dated 31 March 2017

EQUILIBRE NERVEUX is a food supplement declared in France. Status: déclaré en France, commercialisation possible : l'administration ne s'est pas opposée à la déclaration (ce n'est ni une autorisation ni une évaluation de sécurité). 1 point in its composition requires a check (prohibited substance, dose or novel food).

Brand
not provided
Food business operator placing the product on the market
PIERRE FABRE MEDICAMENT
Status
Déclaré en France, commercialisation possible : l'administration ne s'est pas opposée à la déclaration (ce n'est ni une autorisation ni une évaluation de sécurité)
Form
Gélule
Daily dose
2 gélules/jour
Directions for use
1 gélule matin et soir à prendre avec un grand verre d'eau
Not recommended for (according to the manufacturer)
Sous antidépresseurs
Objectives stated by the manufacturer (these are not authorised claims)
Système nerveux

Declaration 280022, procedure Article 16. Compl'Alim, food supplement declarations (France), retrieved 23 October 2026.

Regulatory points

Declared composition

Plants

PlantPartPreparationPer day
Griffonia simplicifolia (DC.) Baill.GraineExtrait sec aqueux200 mg
Crocus sativus L.StigmatesExtrait sec hydroalcoolique10 mg

Vitamins and minerals

Compl'Alim does not publish vitamin and mineral doses. The references below help you read the product label: EFSAEuropean Food Safety Authority. safety limit for adults and maximum dose set in France per product (Order of 9 May 2006, not revised since November 2006).

Declared formNutrientEFSA limit, adults Maximum dose in France
Oxyde de magnésiumMagnésium250 mg300 mg

Additives

E470b, E460, E464

Other ingredients

maltodextrine

List from the declaration, administrative decision dated (Compl'Alim, food supplement declarations (France)).

List recorded in 2017. Photograph the packaging to check whether it has changed. Photograph the packaging

Label warnings

En raison de la présence de 5-HTP, il est conseillé d'éviter de l'associer à des antidépresseurs sans avis médical. Des effets sont aussi à noter sur la somnolence.

This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.

List recorded in 2017. Photograph the packaging to check whether it has changed.

Enter to analyse, Shift+Enter for a new line